Xenomis develops nutraceutical products based upon new science from an exclusive Harvard Medical School license, plus proprietary Australian Extraction technology to develop concentrated Xeno Factors. 

 

Based on patented knowledge from Harvard University Medical School, called Xenohormesis, and a unique red wine grape skin extraction process which concentrates natural health-enhancing molecules called Xeno Factors, Xenomis was formed in 2005 to both pursue research and develop marketable nutraceuticals containing Xeno Factors to improve human health and wellness.

 

The unique red wine grape skin extraction process, developed in the wine growing region of southern Australia, is uniquely designed to extract and concentrate Xeno Factor molecules from red grape skins chemically known as - polyphenols.  These molecules are known to be powerful antioxidants and also have been found to be extremely bioactive, possessing many health benefits. This Australian Extract can be added to other proven polyphenols from natural plants as a health juice or added to other nutraceuticals or other health enhancing products.

 

Xenomis is developing and partnering to make nutraceutical products containing highly concentrated Xeno Factors which are known to have powerful health enhancing effects in delaying the aging process and improved human function.